Harmony Biosciences Holdings, a commercial stage biotech developing therapies for narcolepsy and other CNS disorders, filed on Monday with the SEC to raise up to $100 million in an initial public ...

At CNS Summit 2020, AiCure will join Merck and Kent State University to discuss the industry need to democratize access to these algorithms to enhance their validity and deepen the pool of ...

Praxis Precision Medicines, a Phase 2 biotech developing therapies for CNS disorders using genetic insights, filed on Friday with the SEC to raise up to $100 million in an initial public offering ...

CHICAGO, IL / ACCESSWIRE / December 7, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R ...

45 clinical trial sites of the 60 sites selected across the U.S., Italy, France, Spain, and Switzerland open and enrolling patients HOUSTON, TX / ACCESSWIRE / May 25, 2023 / CNS Pharmaceuticals, Inc. ...